Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Compare regional ETFs by cash flow to find the strongest income generator. A quick guide to optimize regional yield strategies.
26,816 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Bitcoin sits at a crossroads as whales accumulate and policy debates heat up. This piece breaks down how many BTC cou...
Even as Ethereum faces a brutal price decline, new wallet data shows ethereum more holders than Bitcoin. Analysts say...
As markets wobble in early 2026, utility ETFs provide a steady dividend stream and a shield against volatility. This ...
A growing number of retirees are deploying a blended 6.4% yield strategy, combining high-quality dividends with real ...
Tech sell-off drags crypto lower as Bitcoin moves in step with slumping tech shares; analysts warn of continued volat...
As markets stabilize in 2026, a growing argument centers on placing the Vanguard Mid-Cap ETF (VO) inside a Roth IRA t...
Bitwise CIO Matt Hougan says the crypto winter persists, but fundamentals are strengthening, laying the groundwork fo...
Stocks drift lower on March 10, 2026 as oil prices slide, muting tech gains. This stock market live march update expl...
This original millionaire interview-style guide dives into the daily habits, smart choices, and concrete steps that h...
Bitcoin faces a potential surge as AI arms spending and geopolitical risks boost liquidity. arthur hayes predicts rac...
Analysts say XRP would require a rare confluence of market, regulatory, and macro factors to hit $200 per token. Here...